← All stories
Health, Longevity & Biohacking

Otvos says ‘fluffy’ LDL does not offset risk when LDL particle count is high

By Egleze Editorial Desk · Published August 3, 2026 · Peter Attia Drive · 402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample
Otvos says ‘fluffy’ LDL does not offset risk when LDL particle count is high
Peter Attia Drive
Peter Attia Drive
402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample

What was said

""I would say that's uh a facious idea. Um, and and the data that I mentioned supports it completely.""

Asked about patients who argue that large, “buoyant” LDL particles make high LDL particle number less concerning, Otvos rejects the claim. He says analyses show LDL size does not add predictive value once LDL particle number is accounted for, and cites familial hypercholesterolaemia as an example where LDL particles can be large yet risk remains high.

Verification status

Attributed speaker claim

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Source and context

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Programme
Peter Attia Drive
Episode
402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample
Clip time
34:00
Original source
Watch the source segment →
From this episode
Peter Attia Drive
Peter Attia Drive

402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample

August 3, 2026 · 2h 27m · 7 Egleze moments
Read episode summary and key points →

More moments from this episode

Health, Longevity & BiohackingOtvos says MVX mortality-risk score is ‘virtually unassociated’ with age→Health, Longevity & BiohackingNMR ‘glyc’ inflammation marker described as more stable than CRP→AI & TechOtvos says NMR plus machine learning can output ApoB and lipid panel cheaply→Health, Longevity & BiohackingOtvos says unpublished Diabetes Prevention Program analysis found LPIR outperformed insulin→
More stories More from Peter Attia Drive